OTC/SmallCap IRW

CLSA:Fosun's Outstanding Performance on ESG, Solidifying Leadership in Sustainable Development

HONG KONG, Oct. 8, 2021 /PRNewswire/ -- CLSA has published the first ESG deep-dived research report on Fosun International (HK 656). The report has pointed out that Fosun's ESG mission is clear: actively address the growing demand for corporate sustainability. Fosun has a rigorous structure and p...

2021-10-08 13:42 23196

Resonant Inc. Expands Strategic Partnership with Murata Manufacturing Co., Ltd., the World's Leading RF Module and Filter Provider

Resonant's XBAR® Technology to be Leveraged Across Additional Bands AUSTIN, Texas, Oct. 7, 2021 /PRNewswire/ -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, has expan...

2021-10-07 11:09 8607

Sasol announces lead role in feasibility study for the Boegoebaai Green Hydrogen Project

JOHANNESBURG, Oct. 7, 2021 /PRNewswire/ -- The Boegoebaai "green hydrogen" development has been designated a Strategic Integrated Project (SIP) in the South African National Development Plan and is located in the Namakwa Special Economic Zone (SEZ). The project's location and classification as a ...

2021-10-07 03:11 7770

NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference

SHELTON, Conn., Oct. 5, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, presented an update of its Pan-Coronavirus COVID-19 Drug Development Program at t...

2021-10-05 18:45 10898

/DISREGARD RELEASE: Infineon Technologies AG/

We are advised by Infineon Technologies AG that journalists and other readers should disregard the news release, "Infineon launches SLS37 V2X Hardware Security Module to safeguard vehicle to everything communication" issued onOct. 4, 2021 by Infineon Technologies AG as the release was transmitted...

2021-10-05 16:10 11791

Infineon launches SLS37 V2X Hardware Security Module to safeguard vehicle to everything communication

MUNICH, Oct. 4, 2021 /PRNewswire/ -- To provide the highest level of protection, Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is launching the SLS37 V2X hardware security module (HSM), a plug-and-play security solution for vehicle to everything communication (V2X). The SLS37 V2X HSM is base...

2021-10-04 11:03 6970

BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission

VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company"), announced today that it has started its plannedin vivo animal toxicology study of CoviDTH in parallel with the preparation of an IND submission. Under the terms ...

2021-09-28 20:00 6332

BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins

- Potential for superior tolerability to mRNA and Adenovirus Vector vaccines - Production Agreement signed with Millipore-Sigma for SARS-CoV-2 Vaccine Supply VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), a...

2021-09-23 15:00 5563

Sasol commits to net zero ambition by 2050, triples 2030 GHG emission reduction targets

JOHANNESBURG, Sept. 22, 2021 /PRNewswire/ -- Sasol Limited (Sasol) today announced its updated strategy that commits it to be at net zero emissions by 2050. This is in line with Sasol's commitment to accelerate its transition to a low carbon world in support of the objectives of the Paris Agreeme...

2021-09-22 22:07 7252

Arçelik joins the UN Global Compact CFO Taskforce to align finance and sustainability for real world change

ISTANBUL, Sept. 22, 2021 /PRNewswire/ -- Arçelik A.Ş. (IST: ARCLK) ("Arçelik"), the global leading consumer durables and electronics manufacturer, has announced that Polat Şen, the Chief Financial Officer (CFO) of Arçelik has joined the UN Global Compact CFO Taskforce. With 60 members across 23 ...

2021-09-22 18:48 5959

Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug

SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the significant advantages gained by remdesivir encapsulation ...

2021-09-22 18:45 5069

BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone

VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine manufacturing partner Bio Elpida inLyon, France, has reached major milestones in the development of the bioproduction proce...

2021-09-17 15:00 4960

Sasol, Haldor Topsøe expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally

JOHANNESBURG, Sept. 15, 2021 /PRNewswire/ -- Haldor Topsøe and Sasol have expanded collaboration to jointly license and develop their technologies for sustainable liquid fuels and chemicals production through Fischer-Tropsch (FT) technology. Sasol and Topsøe currently offer integrated end-to-end...

2021-09-15 20:23 7360

10,000 green hydrogen generators per month: groundbreaking for Enapter electrolyser mass production in North Rhine-Westphalia

Acting, not talking. -  Enapter Campus enables mass production of AEM Electrolysers and serves as a blueprint for further Enapter production facilities worldwide -  Electrolyser production, warehouse storage and offices, as well as research and development laboratories will be built over 82,000...

2021-09-15 04:25 4836

BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs

VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...

2021-09-14 15:00 5402

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...

2021-09-13 19:00 5800

Sasol and Central Energy Fund sign strategic MOU to accelerate gas development in South Africa

JOHANNESBURG, Sept. 7, 2021 /PRNewswire/ -- Sasol and the Central Energy Fund (CEF) have signed a memorandum of understanding (MOU) to collaborate on accelerating the development of gas solutions inSouth Africa. This agreement brings togetherSouth Africa's two leading pioneers of the gas industry...

2021-09-07 20:58 5929

Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration

VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Sept. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that the Scientific Advisor for its CoviDTH program,Yvelise Barrios, MD, PhD, and Clinical Immuno...

2021-09-07 20:00 6022

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease

-- Using NeuExcell's neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington's Disease. -- Spark Therapeutics' excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform ma...

2021-09-07 12:00 3207

Fosun International Officially Selected as a Constituent Stock of Hang Seng ESG 50 Index

HONG KONG, Sept. 6, 2021 /PRNewswire/ -- Fosun International officially was selected as a constituent stock of Hang Seng ESG 50 Index (top 50 large-to-mid cap). Hang Seng ESG 50 Index aims at capturing the overall performance of Top 50 ESG leaders with relatively high market capitalization listed...

2021-09-06 16:51 7160
1 ... 28293031323334 ... 50